Profund Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-64,969
| Closed | -$185K | – | 1082 |
|
|
2024
Q1 | $185K | Buy |
64,969
+40,362
| +164% | +$115K | 0.01% | 1087 |
|
|
2023
Q4 | $362K | Buy |
24,607
+5,239
| +27% | +$77.1K | 0.02% | 682 |
|
|
2023
Q3 | $355K | Buy |
19,368
+5,558
| +40% | +$102K | 0.02% | 582 |
|
|
2023
Q2 | $298K | Buy |
13,810
+871
| +7% | +$18.8K | 0.02% | 725 |
|
|
2023
Q1 | $380K | Buy |
+12,939
| New | +$380K | 0.02% | 614 |
|